Tibet Cheezheng Stock Hits Day Low of CNY 23.31 Amid Price Pressure

Tibet Cheezheng Tibetan Medicine Co., Ltd. experienced a notable decline today, with the stock dropping by 3.88% as it reached an intraday low of CNY 23.31. This performance contrasts with the broader market, as the China Shanghai Composite index fell by only 1.24% during the same period. Over the past week, Tibet Cheezheng has seen a decrease of 4.58%, while its monthly performance reflects a slight decline of 3.08%. In the longer term, the stock has underperformed, with a year-to-date drop of 1.48% compared to the market's marginal decline of 0.3%. Over the past three years, the stock has decreased by 10.35%, significantly lagging behind the market's growth of 22.32%. Financial metrics indicate challenges for the company, including a low dividend payout ratio of 0% and a return on capital employed (ROCE) of just 14.34%. Additionally, raw material costs have surged by 101.24% year-over-year, impacting profitability. Despite a market capitalization of CNY 13,732 million and a P/E ratio of 28.00, the company has struggled to maintain competitive growth in the pharmaceuticals and biotechnology sector.